Acute pancreatitis resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
Line 49: | Line 49: | ||
======Organ Failure====== | ======Organ Failure====== | ||
* Organ failure is defined as a score of 2 or more for one of these three organ systems using the modified Marshall scoring system.<ref name="MarshallCook1995">{{cite journal|last1=Marshall|first1=John C.|last2=Cook|first2=Deborah J.|last3=Christou|first3=Nicolas V.|last4=Bernard|first4=Gordon R.|last5=Sprung|first5=Charles L.|last6=Sibbald|first6=William J.|title=Multiple Organ Dysfunction Score|journal=Critical Care Medicine|volume=23|issue=10|year=1995|pages=1638–1652|issn=0090-3493|doi=10.1097/00003246-199510000-00007}}</ref> | * Organ failure is defined as a score of 2 or more for one of these three organ systems using the modified Marshall scoring system.<ref name="MarshallCook1995">{{cite journal|last1=Marshall|first1=John C.|last2=Cook|first2=Deborah J.|last3=Christou|first3=Nicolas V.|last4=Bernard|first4=Gordon R.|last5=Sprung|first5=Charles L.|last6=Sibbald|first6=William J.|title=Multiple Organ Dysfunction Score|journal=Critical Care Medicine|volume=23|issue=10|year=1995|pages=1638–1652|issn=0090-3493|doi=10.1097/00003246-199510000-00007}}</ref> | ||
* '''Transient organ failure''' = organ failure resolves within 48 h | |||
* '''Persistent organ failure''' = organ failure persists for >48 h<ref name="Johnson-2004">{{Cite journal | last1 = Johnson | first1 = CD. | last2 = Abu-Hilal | first2 = M. | title = Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. | journal = Gut | volume = 53 | issue = 9 | pages = 1340-4 | month = Sep | year = 2004 | doi = 10.1136/gut.2004.039883 | PMID = 15306596 }}</ref><ref name="Mofidi-2006">{{Cite journal | last1 = Mofidi | first1 = R. | last2 = Duff | first2 = MD. | last3 = Wigmore | first3 = SJ. | last4 = Madhavan | first4 = KK. | last5 = Garden | first5 = OJ. | last6 = Parks | first6 = RW. | title = Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. | journal = Br J Surg | volume = 93 | issue = 6 | pages = 738-44 | month = Jun | year = 2006 | doi = 10.1002/bjs.5290 | PMID = 16671062 }}</ref><ref name="Lytras-2008">{{Cite journal | last1 = Lytras | first1 = D. | last2 = Manes | first2 = K. | last3 = Triantopoulou | first3 = C. | last4 = Paraskeva | first4 = C. | last5 = Delis | first5 = S. | last6 = Avgerinos | first6 = C. | last7 = Dervenis | first7 = C. | title = Persistent early organ failure: defining the high-risk group of patients with severe acute pancreatitis? | journal = Pancreas | volume = 36 | issue = 3 | pages = 249-54 | month = Apr | year = 2008 | doi = 10.1097/MPA.0b013e31815acb2c | PMID = 18362837 }}</ref> | |||
{| {{table}} | {| {{table}} | ||
Line 81: | Line 86: | ||
|- | |- | ||
|} | |} | ||
<sup>†</sup> A score for patients with pre-existing chronic renal failure depends on the extent of further deterioration of baseline renal function. | <sup>†</sup> A score for patients with pre-existing chronic renal failure depends on the extent of further deterioration of baseline renal function. No formal correction exists for a baseline creatinine ≥134 μmol/l or ≥1.4 mg/dl. | ||
====Local Complications==== | ====Local Complications==== |
Revision as of 22:54, 4 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]
Definition
Diagnostic Criteria
- Diagnosis is established by the presence of two of the three following criteria:[1]
- [1] Abdominal pain consistent with acute pancreatitis.
- ▸ Acute onset of a persistent, severe, epigastric pain often radiating to the back.
- [2] Serum lipase or amylase ≥ 3 x ULN.
- [3] Characteristic findings on contrast-enhanced CT, MRI, or transabdominal US.
Types of Acute Pancreatitis
Interstitial Edematous Pancreatitis
- Acute inflammation of the pancreatic parenchyma and peripancreatic tissues, but without recognizable tissue necrosis.
- CECT criteria
- ▸ Pancreatic parenchyma enhancement by intravenous contrast agent.
- ▸ No findings of peripancreatic necrosis.
Necrotizing Pancreatitis
- Inflammation associated with pancreatic parenchymal necrosis and/or peripancreatic necrosis.
- CECT criteria
- ▸ Lack of pancreatic parenchymal enhancement by intravenous contrast agent.
- ▸ Presence of findings of peripancreatic necrosis.
Infected Pancreatic Necrosis
- Should be considered in patients with necrotizing pancreatitis who deteriorate or fail to improve after 7–10 days of hospitalization.[1]
- May be presumed by the presence of extraluminal gas on CECT or when fine-needle aspiration is positive for bacteria and/or fungi on Gram stain and culture.[2]
- Antibiotics able to penetrate pancreatic necrosis (such as carbapenems, quinolones, and metronidazole) may be useful in delaying or sometimes totally avoiding intervention.[3][4]
Complications
Organ Failure
- Organ failure is defined as a score of 2 or more for one of these three organ systems using the modified Marshall scoring system.[5]
- Transient organ failure = organ failure resolves within 48 h
- Persistent organ failure = organ failure persists for >48 h[6][7][8]
Organ System | 0 | 1 | 2 | 3 | 4 |
Respiratory PaO2/FiO2 |
>400 | 301-400 | 201-300 | 101-200 | ≤101 |
Renal† Creatinine (μmol/l) Creatinine (mg/dl) |
≤134 <1.4 |
134-169 1.4-1.8 |
170-310 1.9-3.6 |
311-439 3.6-4.9 |
>439 >4.9 |
Cardiovascular Systolic Blood Pressure (mmHg) |
>90 | <90, fluid responsive | <90, not fluid responsive | <90, pH <7.3 | <90, pH <7.2 |
† A score for patients with pre-existing chronic renal failure depends on the extent of further deterioration of baseline renal function. No formal correction exists for a baseline creatinine ≥134 μmol/l or ≥1.4 mg/dl.
Local Complications
- Should be suspected when there is persistence/recurrence of abdominal pain, secondary increases in pancreatic enzyme, increasing organ dysfunction, or the development of signs of sepsis.[1]
Acute Peripancreatic Fluid Collection (APFC)
- Peripancreatic fluid associated with interstitial edematous pancreatitis with no associated peripancreatic necrosis. This term applies only to areas of peripancreatic fluid seen within the first 4 weeks after onset of interstitial edematous pancreatitis and without the features of a pseudocyst.
- CECT criteria
- ▸ Occurs in the setting of interstitial edematous pancreatitis.
- ▸ Homogeneous collection with fluid density.
- ▸ Confined by normal peripancreatic fascial planes.
- ▸ No definable wall encapsulating the collection.
- ▸ Adjacent to pancreas (no intrapancreatic extension).
Pancreatic Pseudocyst
- An encapsulated collection of fluid with a well defined inflammatory wall usually outside the pancreas with minimal or no necrosis. This entity usually occurs more than 4 weeks after onset of interstitial edematous pancreatitis to mature.
- CECT criteria
- ▸ Well circumscribed, usually round or oval.
- ▸ Homogeneous fluid density.
- ▸ No non-liquid component.
- ▸ Well defined wall; that is, completely encapsulated.
- ▸ Maturation usually requires >4 weeks after onset of acute pancreatitis; occurs after interstitial edematous pancreatitis.
Acute necrotic collection (ANC)
- A collection containing variable amounts of both fluid and necrosis associated with necrotizing pancreatitis; the necrosis can involve the pancreatic parenchyma and/or the peripancreatic tissues.
- CECT criteria
- ▸ Occurs only in the setting of acute necrotising pancreatitis.
- ▸ Heterogeneous and non-liquid density of varying degrees in different locations (some appear homogeneous early in their course).
- ▸ No definable wall encapsulating the collection.
- ▸ Location—intrapancreatic and/or extrapancreatic.
Walled-off necrosis (WON)
- A mature, encapsulated collection of pancreatic and/or peripancreatic necrosis that has developed a well defined inflammatory wall. WON usually occurs >4 weeks after onset of necrotising pancreatitis.
- CECT criteria
- ▸ Heterogeneous with liquid and non-liquid density with varying degrees of loculations (some may appear homogeneous).
- ▸ Well defined wall, that is, completely encapsulated.
- ▸ Location—intrapancreatic and/or extrapancreatic.
- ▸ Maturation usually requires 4 weeks after onset of acute necrotizing pancreatitis.
Severity of Acute Pancreatitis
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Acute pancreatitis from any cause may be life-threatening especially if it progresses to necrotizing pancreatitis.
Common Causes
- Idiopathic
- Ischaemic necrosis of pancreas from vascular sources such as vasculitis and atherosclerosis
- Medication such as 5-mercaptopurine, azathioprine, 5-DDI[9]
- Metabolic - hypercalcemia and hyperphosphatemia
- Post - ERCP
- Pregnancy
- Toxins such as venom of brown recluse spider, certain arachnids etc.
Management
Acute Pancreatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Signs & symptoms: severe abdominal pain, breathing difficulty, hypotension, vomiting, fever, cullen's sign, grey turner sign | Check labs - serum amylase, serum lipase, serum triglycerides, abdominal USG, CBC, CECT, MRI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria: Any 2 out of 3 Abdominal pain consistent with disease serum amylase or lipase values > 3 times normal consistent findings from abdominal imaging | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk stratification | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low risk* | High risk** | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General medical ward | ICU | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initiate supportive care Aggressive fluid resuscitation with 250-500 mlRingers Lactate per hr during first 12-24 hours In sever cases give fluid bolus Mild cases - oral liquid feeds In moderate to severe cases enteral feeds, nasogastric or nasojejunal feeds are acceptable | CT scan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Provide adequate analgesia | Pancreatic necrosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stones? | Other causes, treat as per cause | No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Surgical consult Emergency cholecystectomy or ERCP within 24 Hrs of admission | Assess in 1 week | SIRS/Organ failure? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tolerating oral feeds | Not tolerating oral feed | If yes, surgical consultation Think about CT guided percutaneous aspiration & culture | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recovery | Add nutritional support Consider CT scan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lack of improvement/Worsening of clinical status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- * - Low risk: 1. Absence of organ failure. and/or 2. Absence of local complications
- ** - High risk: 1. Transient organ failure. and/or 2. local complications.
The following recommendations are based on 2013 guidelines for Acute pancreatitis treatment based on recommendations given by American college of gastroenterology.[13]
Do's
- Perform abdominal USG in all patients.
- Check serum triglycerides if stones/alcohol not not an etiology.
- Consider pancreatic tumor if age > 40 yrs.
- Use Ringer's Lactate(RL) as first choice agent, use normal saline if RL not available.
- Refer patients with idiopathic acute pancreatitis to centers of excellence.
- Perform elective cholecystectomy for gallstones to prevent recurrences.
- Use antibiotics for infected necrosis, with high penetrance such as carbapenems, quinolones & metronidazole.
- CECT or MRI should be reserved for:[14][15][16]
- Patients who fail to improve clinically (e.g., persistent abdominal pain, fever, nausea, unable to begin oral intake) within the first 48-72 h after admission.
- Patients in whom the diagnosis is unclear.
Dont's
- Do not shift patients with sepsis/organ failure to general ward.
- Do not perform emergency surgery in stable patients with infected necrosis, wait for 3-4 weeks.
References
- ↑ 1.0 1.1 1.2 Banks, PA.; Bollen, TL.; Dervenis, C.; Gooszen, HG.; Johnson, CD.; Sarr, MG.; Tsiotos, GG.; Vege, SS.; Acosta, JM. (2013). "Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus". Gut. 62 (1): 102–11. doi:10.1136/gutjnl-2012-302779. PMID 23100216. Unknown parameter
|month=
ignored (help) - ↑ Banks, PA.; Gerzof, SG.; Langevin, RE.; Silverman, SG.; Sica, GT.; Hughes, MD. (1995). "CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome". Int J Pancreatol. 18 (3): 265–70. doi:10.1007/BF02784951. PMID 8708399. Unknown parameter
|month=
ignored (help) - ↑ Petrov, MS.; Shanbhag, S.; Chakraborty, M.; Phillips, AR.; Windsor, JA. (2010). "Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis". Gastroenterology. 139 (3): 813–20. doi:10.1053/j.gastro.2010.06.010. PMID 20540942. Unknown parameter
|month=
ignored (help) - ↑ van Santvoort, HC.; Bakker, OJ.; Bollen, TL.; Besselink, MG.; Ahmed Ali, U.; Schrijver, AM.; Boermeester, MA.; van Goor, H.; Dejong, CH. (2011). "A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome". Gastroenterology. 141 (4): 1254–63. doi:10.1053/j.gastro.2011.06.073. PMID 21741922. Unknown parameter
|month=
ignored (help) - ↑ Marshall, John C.; Cook, Deborah J.; Christou, Nicolas V.; Bernard, Gordon R.; Sprung, Charles L.; Sibbald, William J. (1995). "Multiple Organ Dysfunction Score". Critical Care Medicine. 23 (10): 1638–1652. doi:10.1097/00003246-199510000-00007. ISSN 0090-3493.
- ↑ Johnson, CD.; Abu-Hilal, M. (2004). "Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis". Gut. 53 (9): 1340–4. doi:10.1136/gut.2004.039883. PMID 15306596. Unknown parameter
|month=
ignored (help) - ↑ Mofidi, R.; Duff, MD.; Wigmore, SJ.; Madhavan, KK.; Garden, OJ.; Parks, RW. (2006). "Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis". Br J Surg. 93 (6): 738–44. doi:10.1002/bjs.5290. PMID 16671062. Unknown parameter
|month=
ignored (help) - ↑ Lytras, D.; Manes, K.; Triantopoulou, C.; Paraskeva, C.; Delis, S.; Avgerinos, C.; Dervenis, C. (2008). "Persistent early organ failure: defining the high-risk group of patients with severe acute pancreatitis?". Pancreas. 36 (3): 249–54. doi:10.1097/MPA.0b013e31815acb2c. PMID 18362837. Unknown parameter
|month=
ignored (help) - ↑ Yi, GC.; Yoon, KH.; Hwang, JB. (2012). "Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease". Pediatr Gastroenterol Hepatol Nutr. 15 (4): 272–5. doi:10.5223/pghn.2012.15.4.272. PMID 24010098. Unknown parameter
|month=
ignored (help) - ↑ Rebours, V.; Vullierme, MP.; Hentic, O.; Maire, F.; Hammel, P.; Ruszniewski, P.; Lévy, P. (2012). "Smoking and the course of recurrent acute and chronic alcoholic pancreatitis: a dose-dependent relationship". Pancreas. 41 (8): 1219–24. doi:10.1097/MPA.0b013e31825de97d. PMID 23086245. Unknown parameter
|month=
ignored (help) - ↑ Köhler, H.; Lankisch, PG. (1987). "Acute pancreatitis and hyperamylasaemia in pancreatic carcinoma". Pancreas. 2 (1): 117–9. PMID 2437571.
- ↑ Bleichner, JP.; Guillou, YM.; Martin, L.; Seguin, P.; Mallédant, Y. (1998). "-Pancreatitis after blunt injuries to the abdomen-". Ann Fr Anesth Reanim. 17 (3): 250–3. PMID 9750738.
- ↑ Tenner, S.; Baillie, J.; DeWitt, J.; Vege, SS. (2013). "American College of Gastroenterology guideline: management of acute pancreatitis". Am J Gastroenterol. 108 (9): 1400–15, 1416. doi:10.1038/ajg.2013.218. PMID 23896955. Unknown parameter
|month=
ignored (help) - ↑ Arvanitakis, M.; Delhaye, M.; De Maertelaere, V.; Bali, M.; Winant, C.; Coppens, E.; Jeanmart, J.; Zalcman, M.; Van Gansbeke, D. (2004). "Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis". Gastroenterology. 126 (3): 715–23. PMID 14988825. Unknown parameter
|month=
ignored (help) - ↑ Zaheer, A.; Singh, VK.; Qureshi, RO.; Fishman, EK. (2013). "The revised Atlanta classification for acute pancreatitis: updates in imaging terminology and guidelines". Abdom Imaging. 38 (1): 125–36. doi:10.1007/s00261-012-9908-0. PMID 22584543. Unknown parameter
|month=
ignored (help) - ↑ Bollen, TL.; Singh, VK.; Maurer, R.; Repas, K.; van Es, HW.; Banks, PA.; Mortele, KJ. (2011). "Comparative evaluation of the modified CT severity index and CT severity index in assessing severity of acute pancreatitis". AJR Am J Roentgenol. 197 (2): 386–92. doi:10.2214/AJR.09.4025. PMID 21785084. Unknown parameter
|month=
ignored (help)